Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ASPI 
ASP Isotopes Inc. Common Stock (ASPI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/20/2025: ASPI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $11
1 Year Target Price $11
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 310.69% | Avg. Invested days 34 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/20/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.11B USD | Price to earnings Ratio - | 1Y Target Price 11 |
Price to earnings Ratio - | 1Y Target Price 11 | ||
Volume (30-day avg) 1 | Beta 3.31 | 52 Weeks Range 3.65 - 14.49 | Updated Date 10/19/2025 |
52 Weeks Range 3.65 - 14.49 | Updated Date 10/19/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.4 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -998.76% |
Management Effectiveness
Return on Assets (TTM) -21.64% | Return on Equity (TTM) -469.6% |
Valuation
Trailing PE - | Forward PE 54.35 | Enterprise Value 860308512 | Price to Sales(TTM) 241.59 |
Enterprise Value 860308512 | Price to Sales(TTM) 241.59 | ||
Enterprise Value to Revenue 187.78 | Enterprise Value to EBITDA -12.17 | Shares Outstanding 110574009 | Shares Floating 66002804 |
Shares Outstanding 110574009 | Shares Floating 66002804 | ||
Percent Insiders 23.03 | Percent Institutions 48.3 |
Upturn AI SWOT
ASP Isotopes Inc. Common Stock
Company Overview
History and Background
ASP Isotopes Inc. (ASPI) was founded to commercialize technologies for the separation and enrichment of stable isotopes. They focus on supplying enriched isotopes for various applications.
Core Business Areas
- Isotope Enrichment: Production and sale of enriched isotopes for medical, industrial, and research applications.
Leadership and Structure
Information about specific leadership details and organizational structure is limited from general public sources. Requires accessing company reports and filings.
Top Products and Market Share
Key Offerings
- Silicon-28: Enriched Silicon-28 is used in semiconductor manufacturing, particularly for high-performance computing and quantum computing applications. Market share data is not readily available, but competitors include companies specializing in advanced materials and isotope production. Potential competitors: Cambridge Isotope Laboratories, Isoflex USA
Market Dynamics
Industry Overview
The stable isotope market is driven by increasing demand in medical imaging, pharmaceutical research, semiconductor manufacturing, and quantum computing. It is a niche market with specific technical requirements.
Positioning
ASP Isotopes aims to position itself as a key supplier of Silicon-28 and other enriched isotopes, targeting high-value applications. Their competitive advantage relies on proprietary enrichment technologies.
Total Addressable Market (TAM)
TAM for enriched isotopes is estimated to be in the hundreds of millions of dollars and growing, particularly with advancements in quantum computing and medical imaging. ASPI aims to capture a significant share through technology and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Proprietary isotope enrichment technology
- Focus on high-value applications
- Potential for strong growth in emerging markets (e.g., quantum computing)
Weaknesses
- Small market capitalization
- Limited operating history
- Dependence on key customers and contracts
- No sustained record of profitability
Opportunities
- Expanding applications for enriched isotopes
- Strategic partnerships with semiconductor manufacturers
- Government funding for isotope research and development
Threats
- Competition from established isotope suppliers
- Technological obsolescence
- Fluctuations in commodity prices
- Economic downturns affecting research and development budgets
Competitors and Market Share
Key Competitors
- NXST
- HON
- MRK
- ILMN
Competitive Landscape
ASPI is a smaller player in the overall market and must compete on technology and niche applications. Competitors have greater resources and established customer relationships.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data unavailable without access to ASP Isotopes Inc.'s financial records.
Future Projections: Future growth projections unavailable without analyst estimates specific to ASP Isotopes Inc.
Recent Initiatives: ASPI is focused on expanding production capacity for Silicon-28 and securing partnerships within the semiconductor and quantum computing industries.
Summary
ASP Isotopes Inc. is a small company focused on enriched isotope production, particularly Silicon-28. They have promising technology and target growing markets like quantum computing. However, they face challenges related to competition from established players and need to achieve profitability. Their future success depends on securing strategic partnerships and expanding production efficiently.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- Company Filings
- Industry reports
- Financial News Outlets
Disclaimers:
The data provided is based on publicly available information and may not be entirely accurate or complete. This analysis is for informational purposes only and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ASP Isotopes Inc. Common Stock
Exchange NASDAQ | Headquaters Washington, DC, United States | ||
IPO Launch date 2022-11-10 | COO & Interim CEO Mr. Robert Ainscow | ||
Sector Basic Materials | Industry Chemicals | Full time employees 136 | Website https://aspisotopes.com |
Full time employees 136 | Website https://aspisotopes.com | ||
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-67/68, Nickel-64, and Xenon 129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. ASP Isotopes Inc. was incorporated in 2021 and is based in Washington, District Of Columbia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.